Now maybe we’re getting somewhere.

Results from a study conducted by Stanford researchers working with Apple showed that using the Apple Watch to detect atrial fibrillation probably won’t cause an epidemic of worrisome diagnoses. But it didn’t really answer most of the questions doctors or consumers have about using the watch in this way.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • The control group gets nothing? A blinded placebo-controlled study would give the control group Apple Watches that produces alerts randomly at the same rate as in the experimental group.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy